Figure 1From: FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients Consolidated Standards of Reporting Trials (CONSORT) diagram. ITT, intention to treat; mITT, modified intention to treat; LET, letrozole alone; LET + ZOL, letrozole plus zoledronic acid.Back to article page